These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Treatment thresholds for osteoporosis in men on androgen deprivation therapy: T-score versus FRAX. Adler RA, Hastings FW, Petkov VI. Osteoporos Int; 2010 Apr; 21(4):647-53. PubMed ID: 19533207 [Abstract] [Full Text] [Related]
5. Application of the World Health Organization Fracture Risk Assessment Tool to predict need for dual-energy X-ray absorptiometry scanning in postmenopausal women. Chao AS, Chen FP, Lin YC, Huang TS, Fan CM, Yu YW. Taiwan J Obstet Gynecol; 2015 Dec; 54(6):722-5. PubMed ID: 26700992 [Abstract] [Full Text] [Related]
6. Improving bone health in prostate cancer patients starting androgen deprivation therapy: does Fracture Risk Assessment Tool (FRAX®) enhance stratification and targeted management? Sharqawi A, Hewitt K, Alexander C, El-Sakka AI, Lee L. Arch Osteoporos; 2022 Nov 15; 17(1):143. PubMed ID: 36376762 [Abstract] [Full Text] [Related]
7. Prevalence of osteopenia and osteoporosis by central and peripheral bone mineral density in men with prostate cancer during androgen-deprivation therapy. Bruder JM, Ma JZ, Basler JW, Welch MD. Urology; 2006 Jan 15; 67(1):152-5. PubMed ID: 16413352 [Abstract] [Full Text] [Related]
8. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy. Conde FA, Sarna L, Oka RK, Vredevoe DL, Rettig MB, Aronson WJ. Urology; 2004 Aug 15; 64(2):335-40. PubMed ID: 15302490 [Abstract] [Full Text] [Related]
10. Application of a fracture risk algorithm to men treated with androgen deprivation therapy for prostate cancer. Saylor PJ, Kaufman DS, Michaelson MD, Lee RJ, Smith MR. J Urol; 2010 Jun 15; 183(6):2200-5. PubMed ID: 20399451 [Abstract] [Full Text] [Related]
11. Androgen deprivation increases the risk of fracture in prostate cancer patients: a population-based study in Chinese patients. Wu CT, Yang YH, Chen PC, Chen MF, Chen WC. Osteoporos Int; 2015 Sep 15; 26(9):2281-90. PubMed ID: 25990353 [Abstract] [Full Text] [Related]
16. Osteoporosis and prostate cancer: a cross-sectional study of Danish men with prostate cancer before androgen deprivation therapy. Poulsen MH, Frost M, Abrahamsen B, Brixen K, Walter S. Scand J Urol; 2014 Aug 15; 48(4):350-5. PubMed ID: 24548220 [Abstract] [Full Text] [Related]
17. Relationship between bone mineral density and androgen-deprivation therapy in Japanese prostate cancer patients. Yuasa T, Maita S, Tsuchiya N, Ma Z, Narita S, Horikawa Y, Yamamoto S, Yonese J, Fukui I, Takahashi S, Hatake K, Habuchi T. Urology; 2010 May 15; 75(5):1131-7. PubMed ID: 20163839 [Abstract] [Full Text] [Related]
20. Digital X-ray radiogrammetry in the study of osteoporotic fractures: Comparison to dual energy X-ray absorptiometry and FRAX. Kälvesten J, Lui LY, Brismar T, Cummings S. Bone; 2016 May 15; 86():30-5. PubMed ID: 26921822 [Abstract] [Full Text] [Related] Page: [Next] [New Search]